Phospho-Akt1 (Ser473) Antibody [E4M2] Datasheet

Biological Description

Specificity	Phospho-Akt1 (Ser473) Antibody [E4M2] detects endogenous levels of total Akt1 protein only when it is phosphorylated at Ser473.
Background	Phospho‑Akt1 (Ser473) is the activated hydrophobic‑motif form of the serine/threonine kinase Akt1/PKB, a central effector in the class I PI3K pathway that regulates survival, growth, metabolism, and cell‑cycle progression in many mammalian tissues. The Akt1 protein contains an N‑terminal pleckstrin homology domain that binds phosphatidylinositol‑3,4,5‑trisphosphate at the plasma membrane, a central catalytic kinase domain, and a C‑terminal regulatory tail where Ser473 resides as part of a conserved hydrophobic motif. Phosphorylation of Akt1 at Thr308 in the activation loop by PDK1 and at Ser473 in the C‑terminal tail by the mTORC2 complex produces a fully active kinase state with enhanced catalytic efficiency toward downstream substrates. The Ser473‑phosphorylated form of Akt1 phosphorylates Bad, FOXO transcription factors, caspase‑9, c‑Raf, GSK3, TSC2 and mTOR within the mTOR–raptor complex, and also regulates p21 and p27, leading to suppression of pro‑apoptotic signaling, promotion of cell survival, stimulation of glycogen synthesis, and support of cell‑cycle entry and progression. Phospho‑Akt1 (Ser473) participates in insulin and growth‑factor signaling pathways by responding to PI3K‑generated phosphoinositides and transmitting these inputs to metabolic and growth‑controlling effectors, including regulators of glucose transport, glycogen metabolism, and protein synthesis. Akt1 phosphorylation at Ser473 occurs downstream of receptor tyrosine kinases and G‑protein‑coupled receptors that activate class I PI3K, and the resulting phospho‑Akt1 (Ser473) species is detected at the plasma membrane, in the cytoplasm, and in the nucleus, reflecting dynamic redistribution during signaling. Negative regulation of this phospho‑state involves PTEN, which dephosphorylates PIP3 and limits Akt1 membrane recruitment, and phosphatases that directly dephosphorylate Akt1 and reduce the Ser473‑phosphorylated population. Many tumor samples show increased Akt Ser473 phosphorylation and use this modification as a marker for pathway activation, while comparative analyses of Thr308 and Ser473 phosphorylation indicate that Thr308 correlates more directly with Akt catalytic output in some cancers, but Ser473 remains a widely used surrogate of Akt pathway engagement.

Specificity

Phospho-Akt1 (Ser473) Antibody [E4M2] detects endogenous levels of total Akt1 protein only when it is phosphorylated at Ser473.

Background

Phospho‑Akt1 (Ser473) is the activated hydrophobic‑motif form of the serine/threonine kinase Akt1/PKB, a central effector in the class I PI3K pathway that regulates survival, growth, metabolism, and cell‑cycle progression in many mammalian tissues. The Akt1 protein contains an N‑terminal pleckstrin homology domain that binds phosphatidylinositol‑3,4,5‑trisphosphate at the plasma membrane, a central catalytic kinase domain, and a C‑terminal regulatory tail where Ser473 resides as part of a conserved hydrophobic motif. Phosphorylation of Akt1 at Thr308 in the activation loop by PDK1 and at Ser473 in the C‑terminal tail by the mTORC2 complex produces a fully active kinase state with enhanced catalytic efficiency toward downstream substrates. The Ser473‑phosphorylated form of Akt1 phosphorylates Bad, FOXO transcription factors, caspase‑9, c‑Raf, GSK3, TSC2 and mTOR within the mTOR–raptor complex, and also regulates p21 and p27, leading to suppression of pro‑apoptotic signaling, promotion of cell survival, stimulation of glycogen synthesis, and support of cell‑cycle entry and progression. Phospho‑Akt1 (Ser473) participates in insulin and growth‑factor signaling pathways by responding to PI3K‑generated phosphoinositides and transmitting these inputs to metabolic and growth‑controlling effectors, including regulators of glucose transport, glycogen metabolism, and protein synthesis. Akt1 phosphorylation at Ser473 occurs downstream of receptor tyrosine kinases and G‑protein‑coupled receptors that activate class I PI3K, and the resulting phospho‑Akt1 (Ser473) species is detected at the plasma membrane, in the cytoplasm, and in the nucleus, reflecting dynamic redistribution during signaling. Negative regulation of this phospho‑state involves PTEN, which dephosphorylates PIP3 and limits Akt1 membrane recruitment, and phosphatases that directly dephosphorylate Akt1 and reduce the Ser473‑phosphorylated population. Many tumor samples show increased Akt Ser473 phosphorylation and use this modification as a marker for pathway activation, while comparative analyses of Thr308 and Ser473 phosphorylation indicate that Thr308 correlates more directly with Akt catalytic output in some cancers, but Ser473 remains a widely used surrogate of Akt pathway engagement.

Usage Information

Application

WB, IHC

Dilution

WB	IHC
1:5000-1:10000	1:100-1:250

Reactivity

Mouse, Rat, Human

Source

Rabbit Monoclonal Antibody

MW

55 kDa

Storage Buffer

PBS, pH 7.2+50% Glycerol+0.05% BSA+0.01% NaN3

Storage
(from the date of receipt)

-20°C (avoid freeze-thaw cycles), 2 years

References

pmc.ncbi.nlm.nih.gov/articles/PMC3061875/
https://pubmed.ncbi.nlm.nih.gov/15837416/

Phospho-Akt1 (Ser473) Antibody [E4M2]

Biological Description

Usage Information

References

Application Data